Information:
Fel:
ID
22151
Beskrivning
A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.; ODM derived from: https://clinicaltrials.gov/show/NCT00451906
Länk
https://clinicaltrials.gov/show/NCT00451906
Nyckelord
Versioner (1)
- 2017-05-21 2017-05-21 -
Uppladdad den
21 maj 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00451906
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00451906
- StudyEvent: Eligibility
Similar models
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT00451906
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
age
Item
adult patients, >=18 years of age;
boolean
C0001779 (UMLS CUI [1])
locally advanced or metastatic nsclc, squamous cell carcinoma
Item
histologically or cytologically documented inoperable, locally advanced ( stage iii), metastatic (stage iv) or recurrent nsclc other than squamous cell (tumors of mixed histology should be categorized by the predominant cell type);
boolean
C0007131 (UMLS CUI [1,1])
C0677984 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0149782 (UMLS CUI [2])
C0677984 (UMLS CUI [1,2])
C0027627 (UMLS CUI [1,3])
C0149782 (UMLS CUI [2])
ecog
Item
ecog ps status 0-2;
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy >= 12weeks;
boolean
C0023671 (UMLS CUI [1])
hematologic, renal, liver function
Item
adequate renal, liver and hematological function.
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
mixed carcinomas
Item
mixed, non-small and small cell tumors, or mixed adenosquamous carcinomas with a predominant squamous component;
boolean
C0334240 (UMLS CUI [1])
C0206623 (UMLS CUI [2])
C0206623 (UMLS CUI [2])
hemoptysis
Item
hemoptysis (>=1/2 teaspoon of bright red blood) in previous 3 months;
boolean
C0019079 (UMLS CUI [1])
tumor invading major blood vessel
Item
evidence of tumor invading major blood vessels on imaging;
boolean
C1269955 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0005847 (UMLS CUI [1,3])
C0205164 (UMLS CUI [1,2])
C0005847 (UMLS CUI [1,3])
cns metastasis
Item
evidence of cns metastases, even if previously treated.
boolean
C0686377 (UMLS CUI [1])
major surgery, traumatic injury
Item
major surgery (including open biopsy), significant traumatic injury within 28 days prior to enrolment, or anticipation of need for major surgery during study treatment;
boolean
C0679637 (UMLS CUI [1])
C3263723 (UMLS CUI [2])
C3263723 (UMLS CUI [2])
prior chemotherapy
Item
prior chemotherapy for stage iiib/iv disease.
boolean
C1514457 (UMLS CUI [1])